A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software

NCT05903313 — Unknown, 4306 participants, Chang Gung Memorial Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT05903313
StatusUnknown
Study typeObservational
Enrollment4306 (Estimated)
SponsorChang Gung Memorial Hospital (Other)
ConditionsLong QT Syndrome, Sinus Bradycardia, Sinus Tachycardia, Premature Atrial Complexes, Premature Ventricular Complexes, Atrial Flutter, Right Bundle-Branch Block, Left Bundle-Branch Block, Left Ventricular Hypertrophy, Myocardial Infarction
InterventionsChang Gung ECG Abnormality Detection Software (Drug)
Datesstart 2023-10-06, primary completion 2024-01-31 (estimated), completion 2024-02-28 (estimated), first posted 2023-06-15, last updated 2024-01-11
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
All trials for Long QT Syndrome All trials for Sinus Bradycardia All trials of Chang Gung ECG Abnormality Detection Software

-Summary

"Chang Gung ECG Abnormality Detection Software" is a is an artificial intelligence medical signal analysis software that detect whether patients have abnormal ECG signals of 14 diseases by static 12-lead ECG. The 14 diseases were

* Long QT syndrome
* Sinus bradycardia
* Sinus Tachycardia
* Premature atrial complexes
* Premature ventricular complexes
* Atrial Flutter, Right bundle branch block
* Left bundle branch block
* Left Ventricular hypertrophy
* Anterior wall Myocardial Infarction
* Septal wall Myocardial Infarction
* Lateral wall Myocardial Infarction
* Inferior wall Myocardial Infarction
* Posterior wall Myocardial Infarction

The main purpose of this study is to verify whether "Chang Gung ECG Abnormality Detection Software" can correctly identify abnormal ECG signals among patients of 14 diseases. The interpretation standard is the consensus of 3 cardiologists. The results of the software analysis will be used to evaluate the performance of the primary and secondary evaluation indicators.

Expand all sections  ·  Collapse all

+Detailed description

Detailed procedure:

1. Sample source:

This is a retrospective study, and the data comes from the Chang Gung Medical Research Database(CGRD) which was an database form 6 hospitals of Chang Gung Memorial hospital. We collected de-identified static 12-lead ECG data from the database during 2006.01.01\~2019.12.31, and the length of the ECG was 10 seconds.
2. Sampling:

In this experiment, the training dataset and the test dataset ECG were separated. Afterwards, the ECG signals are stratified according to the distribution as the test sample, and all abnormal ECG signals of 14 diseases will be independently sampled from the ECG database of the test set.
3. Confirmation criteria:

The ECG data will be preliminarily screened and selected by the inclusion and exclusion criteria and compiled serial numbers. Then, a cardiologist confirms that the sampling results of the ECG data do not include the exclusion criteria again.
4. Physician interpretation:

The ECG data will be converted into graphic files and submitted to 3 cardiologists for interpretation abnormal ECG signals of 14 related diseases. The results will be used as the standard of this study (Reference).
5. Software interpretation:

After confirming the test standard, input the ECG signal into Chang Gung ECG Abnormality Detection Software to analyze abnormal ECG signals of 14 diseases and interpret each ECG data.
6. Statistical analysis:

After the software interpretation is completed, it will be compared with the results of the physician's interpretation and analyze the primary and secondary evaluation indicators.

+Arms and interventions

ArmTypeInterventionsDescription
Software diagnosisDrug: Chang Gung ECG Abnormality Detection SoftwareSoftware diagnosis with gold standard of 3 cardiologists' interpretation.
  • Chang Gung ECG Abnormality Detection Software (Drug), also known as CGMH-EAD-001: This device is expected to be used for the static 12-lead ECG to detect whether there are abnormal ECG signals related to diseases and outputs the results.

+Outcome measures

Primary outcomes

  • Sensitivity and Specificity [baseline]: The rate of test results that correctly indicate the presence and absence.

Secondary outcomes

  • Area Under the receiver operating characteristic Curve [Baseline]: A graphical plot that illustrates the diagnostic ability of a binary classifier system as its discrimination threshold is varied.

+Eligibility

Sex: All, ages: 20 Years to any

Inclusion Criteria:

* Equal or greater than twenty years old.
* Static 12-lead electrocardiogram of General Electric MUSE XML format file.
* The data comes from the static 12-lead electrocardiogram device of General Electric (model MAC5500).
* The electrocardiogram signal is 500 Hz.
* The Alternating current (AC) filter of the electrocardiogram signal is 60 Hz.
* The resource of original diagnosis was a cardiologist.

Exclusion Criteria:

* Cases used in the model development process.
* Lacks any electrode.
* Contain any electrode lacks a segment.

+Locations (1)

FacilityCityCountryStatus
Chang Gung memorial hospitalTaoyuan CityTaiwan

+Publications

  • Malik J, Devecioglu OC, Kiranyaz S, Ince T, Gabbouj M. Real-Time Patient-Specific ECG Classification by 1D Self-Operational Neural Networks. IEEE Trans Biomed Eng. 2022 May;69(5):1788-1801. doi: 10.1109/TBME.2021.3135622. Epub 2022 Apr 21. PMID 34910628
  • Acharya U.R., Fujita H., Lih O.S., Adam M., Tan J.H., Chua C.K. Automated detection of coronary artery disease using different durations of ECG segments with convolutional neu-ral network Knowl.-Based Syst., 132 (sep.15) (2017), pp. 62-71
  • Bos JM, Attia ZI, Albert DE, Noseworthy PA, Friedman PA, Ackerman MJ. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram. JAMA Cardiol. 2021 May 1;6(5):532-538. doi: 10.1001/jamacardio.2020.7422. PMID 33566059
  • Ribeiro AH, Ribeiro MH, Paixao GMM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MPS, Andersson CR, Macfarlane PW, Meira W Jr, Schon TB, Ribeiro ALP. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat Commun. 2020 Apr 9;11(1):1760. doi: 10.1038/s41467-020-15432-4. PMID 32273514
  • U. Rajendra Acharya, Hamido Fujita, Oh Shu Lih, Yuki Hagiwara, Jen Hong Tan, Muhammad Adam, Automated detection of arrhythmias using different intervals of tachycardia ECG seg-ments with convolutional neural network, Information Sciences, Volume 405, 2017, Pages 81-90, ISSN 0020-0255
  • Jeong DU, Lim KM. Convolutional neural network for classification of eight types of arrhythmia using 2D time-frequency feature map from standard 12-lead electrocardiogram. Sci Rep. 2021 Oct 14;11(1):20396. doi: 10.1038/s41598-021-99975-6. PMID 34650175
  • Kwon JM, Jeon KH, Kim HM, Kim MJ, Lim SM, Kim KH, Song PS, Park J, Choi RK, Oh BH. Comparing the performance of artificial intelligence and conventional diagnosis criteria for detecting left ventricular hypertrophy using electrocardiography. Europace. 2020 Mar 1;22(3):412-419. doi: 10.1093/europace/euz324. PMID 31800031
  • Makimoto H, Hockmann M, Lin T, Glockner D, Gerguri S, Clasen L, Schmidt J, Assadi-Schmidt A, Bejinariu A, Muller P, Angendohr S, Babady M, Brinkmeyer C, Makimoto A, Kelm M. Performance of a convolutional neural network derived from an ECG database in recognizing myocardial infarction. Sci Rep. 2020 May 21;10(1):8445. doi: 10.1038/s41598-020-65105-x. PMID 32439873

+Investigators